Renaissance Technologies’s Voyager Therapeutics VYGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.22M Buy
392,100
+271,900
+226% +$846K ﹤0.01% 2402
2025
Q1
$406K Sell
120,200
-19,700
-14% -$66.6K ﹤0.01% 2822
2024
Q4
$793K Sell
139,900
-138,767
-50% -$787K ﹤0.01% 2612
2024
Q3
$1.63M Buy
278,667
+215,467
+341% +$1.26M ﹤0.01% 2152
2024
Q2
$500K Sell
63,200
-64,900
-51% -$513K ﹤0.01% 2690
2024
Q1
$1.19M Sell
128,100
-55,000
-30% -$512K ﹤0.01% 2380
2023
Q4
$1.55M Sell
183,100
-220,500
-55% -$1.86M ﹤0.01% 2107
2023
Q3
$3.13M Buy
403,600
+90,600
+29% +$702K 0.01% 1580
2023
Q2
$3.58M Buy
313,000
+180,700
+137% +$2.07M 0.01% 1614
2023
Q1
$1.02M Buy
132,300
+13,000
+11% +$100K ﹤0.01% 2472
2022
Q4
$728K Buy
119,300
+2,500
+2% +$15.3K ﹤0.01% 2717
2022
Q3
$691K Buy
116,800
+22,500
+24% +$133K ﹤0.01% 2722
2022
Q2
$557K Buy
+94,300
New +$557K ﹤0.01% 3103
2022
Q1
Sell
-52,617
Closed -$143K 4515
2021
Q4
$143K Sell
52,617
-262,510
-83% -$713K ﹤0.01% 3613
2021
Q3
$829K Sell
315,127
-75,263
-19% -$198K ﹤0.01% 2649
2021
Q2
$1.61M Sell
390,390
-35,011
-8% -$145K ﹤0.01% 2400
2021
Q1
$2M Sell
425,401
-404,858
-49% -$1.91M ﹤0.01% 2227
2020
Q4
$5.94M Buy
830,259
+4,058
+0.5% +$29K 0.01% 1485
2020
Q3
$8.82M Sell
826,201
-19,479
-2% -$208K 0.01% 1229
2020
Q2
$10.7M Sell
845,680
-197,121
-19% -$2.49M 0.01% 1177
2020
Q1
$9.54M Sell
1,042,801
-202,700
-16% -$1.85M 0.01% 1194
2019
Q4
$17.4M Buy
1,245,501
+172,600
+16% +$2.41M 0.01% 1080
2019
Q3
$18.5M Buy
1,072,901
+343,100
+47% +$5.9M 0.02% 1003
2019
Q2
$19.9M Buy
729,801
+237,500
+48% +$6.46M 0.02% 970
2019
Q1
$9.42M Buy
492,301
+60,000
+14% +$1.15M 0.01% 1417
2018
Q4
$4.06M Buy
432,301
+356,901
+473% +$3.36M ﹤0.01% 1851
2018
Q3
$1.43M Sell
75,400
-20,200
-21% -$382K ﹤0.01% 2453
2018
Q2
$1.87M Sell
95,600
-115,965
-55% -$2.27M ﹤0.01% 2293
2018
Q1
$3.98M Buy
+211,565
New +$3.98M ﹤0.01% 1964
2017
Q4
Sell
-33,300
Closed -$686K 3514
2017
Q3
$686K Buy
33,300
+22,800
+217% +$470K ﹤0.01% 2707
2017
Q2
$94K Buy
+10,500
New +$94K ﹤0.01% 3089